Preventing Dual Enrollment in Clinical Trials with Verified Clinical Trials
Enrolling duplicate or professional research subjects in clinical trials poses a serious risk to study integrity and data validity. Even a small number of duplicate participants can compromise trial outcomes, skew results, and prevent studies from achieving their intended endpoints.
Verified Clinical Trials (VCT) offers an industry-leading solution to address this critical issue. As the most extensive and widely adopted clinical trial subject registry, VCT operates across nearly 50 countries, helping research sites and sponsors safeguard their trials from duplicate enrollment.
The system works proactively at the screening stage, identifying individuals attempting to enroll in multiple trials simultaneously. This early detection not only protects study data but also reduces unnecessary costs and operational inefficiencies. VCT continues to monitor and guard against protocol violations throughout the full duration of each trial, acting as a protective layer—like an affordable insurance policy for your research.
Dual enrollment and protocol non-compliance are not limited to a specific phase or indication. From early-phase studies to large-scale phase III and IV trials across various therapeutic areas, the threat is widespread. Verified Clinical Trials is uniquely positioned to provide global coverage and real-time subject verification, offering scalable protection to organizations of all sizes—from nimble biotech firms to large pharmaceutical companies and academic research centers.
With optional biometric verification tools such as fingerprint and facial recognition, Verified Clinical Trials enhances identity verification and ensures that each participant is accurately tracked across studies. Whether you’re managing a single site or a multinational trial, VCT is the trusted partner for maintaining participant integrity and preventing duplicate subject enrollment.
